CRISPR Therapeutics AG (CRSP) Enterprise Value Growth (5y) (2020 - 2026)
CRISPR Therapeutics AG (CRSP) Enterprise Value Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.22% |
| Dec 31, 2025 | -3.17% |
| Sep 30, 2025 | -7.00% |
| Jun 30, 2025 | -12.74% |
| Mar 31, 2025 | -15.83% |
| Dec 31, 2024 | -11.21% |
| Sep 30, 2024 | -25.18% |
| Jun 30, 2024 | -36.15% |
| Mar 31, 2024 | -36.95% |
| Dec 31, 2023 | -29.97% |
| Sep 30, 2023 | -28.99% |
| Jun 30, 2023 | -40.78% |
| Mar 31, 2023 | -40.68% |
| Dec 31, 2022 | -49.91% |
| Sep 30, 2022 | -49.17% |
| Jun 30, 2022 | -49.62% |
| Mar 31, 2022 | -50.05% |
| Dec 31, 2021 | -49.49% |
| Sep 30, 2021 | -61.05% |
| Jun 30, 2021 | -60.01% |